Furthermore, genetic variants of triggering receptor expressed on myeloid cells 2 (TREM2), a trans‐membrane receptor specifically expressed in microglia in the brain, increase the risk of developing neurodegenerative disorders including Alzheimer's disease (AD).4 Here, TREM2 is linked to early-onset autosomal dominant Alzheimer disease.